Head to head comparison of short-term treatment with the NAD+ precursor nicotinamide mononucleotide (NMN) and six weeks of exercise in obese female mice
Obesity is well known to be a major cause of several chronic metabolic diseases, which can be partially counteracted by exercise. This is due, in part, to an upregulation of mitochondrial activity through increased nicotinamide adenine dinucleotide (NAD+). Recent studies have shown that NAD+ levels...
Saved in:
Main Authors: | Golam Mezbah Uddin (Author), Neil A Youngson (Author), David A Sinclair (Author), Margaret J Morris (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety Evaluation for Restorin® NMN, a NAD+ Precursor
by: John Turner, et al.
Published: (2021) -
β-Nicotinamide Mononucleotide (NMN) Administrated by Intraperitoneal Injection Mediates Protection Against UVB-Induced Skin Damage in Mice
by: Zhou X, et al.
Published: (2021) -
The Role of Nicotinamide Mononucleotide Supplementation in Psoriasis Treatment
by: Zhengyi Zhang, et al.
Published: (2024) -
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
by: Rachel S. Fletcher, et al.
Published: (2017) -
Subacute Toxicity Study of Nicotinamide Mononucleotide via Oral Administration
by: Yingnan You, et al.
Published: (2020)